Back to results
US 11,299,513 B2Granted
Cyclative release of peptidic compounds
AssigneeCircle Pharma, Inc.
InventorsMahesh Ramaseshan, Andrew Bockus
Life of this patent
Estimating the term…
Abstract
The present disclosure provides efficient and reliable methods for preparing cyclized peptidic compounds. Advantageously, the currently described methods allow for on-resin cyclization using a limited number of processing steps, while increasing the chemical diversity available for the cyclized peptidic compounds produced.
Claims26
A method for preparing a cyclized peptidic compound of Formula
- the method comprising
- forming a cyclization reaction mixture comprising a thiophilic catalyst, a non-nucleophilic base, and a compound of Formula II:
- under conditions suitable to form the cyclized peptidic compound of Formula I, wherein
- is a solid-phase support;
- R1a is selected from the group consisting of H, NH2, C1-8 alkyl, and C3-8 cycloalkyl;
- L1 is selected from the group consisting of a bond, N—H, and —O—,
- provided that when R1a is NH2, then L1 is a bond;
- and
- provided that when L1 is —O—, then R1a is H, C1-8 alkyl, or C3-8 cycloalkyl;
- R1 is selected from the group consisting of H, NH2, C1-8 alkyl, and C3-8 cycloalkyl,
- provided than when R1 is NH2, then L1 is a bond;
- R2 is H;
- L2 is selected from the group consisting of C2-8 alkylene, C3-8 cycloalkylene, 3- to 8-membered heterocycloalkylene, C6-10 arylene, and 5- to 10-membered heteroarylene, each of which is optionally substituted with from 1 to 4 substituents selected from the group consisting of C1-4 alkyl, cyano, —C(O)Ra, —C(O)ORa, —SRa, —C1-4alkyl-SRa, and oxo, wherein the heterocycoalkylene and heteroarylene each have from 1 to 3 heteroatom ring members each independently selected from the group consisting of N, O and S;
- and
- Ra is selected from the group consisting of H and C1-8 alkyl.
12 more elements
A method for preparing a cyclized peptidic compound comprising
- forming a reaction mixture comprising a metal thiophilic catalyst, a non-nucleophilic base and a linear peptidic compound covalently linked to a solid-phase support via a linker, under conditions suitable to form the cyclized peptidic compound and cleave the cyclized peptidic compound from the solid-phase support,
- wherein the linear peptidic compound is covalently linked to the linker via a thioester moiety, and wherein the linker is covalently linked to the solid-phase support via a sulfonamide moiety, such that cyclization and cleavage of the linear peptidic compound cleaves the thioester moiety to form an amide.
Dependencies are inferred from the claim text.